Välkommen till Via TT - det enkla pressverktyget

Svenska elever presterar på samma nivå som EU/OECD-genomsnittet i en internationell kunskapsmätning som undersöker digital kompetens hos elever i årskurs 8. Samtidigt saknar en stor andel elever grundläggande kunskaper i att värdera information på nätet. Det visar den internationella studien ICILS 2023 som även undersöker kunskaper i programmering och problemlösning.

The European Institute of Innovation and Technology (EIT) invites you to celebrate women entrepreneurs driving innovation and investment in Europe. The EIT Community will be hosting the INNOVEIT Conference which will feature industry leaders like Inga Grieger, Katarzyna Piasecki and Laura Wirsztel. A pitch session will showcase pioneering women-led ventures shaping the future of technology. Exclusive insights: Conference attendees will gain access to the latest research findings from the study “Women founders in European deep tech startups” by the initiative EIT Supernovas, revealing women’s impact in deep tech and the launch of the new Data Room which enhances visibility for women-led startups and scaleups by connecting them with potential investors.

Kempten. At last, used and professionally refurbished e-bikes become available in the popular company bike leasing programme. Rebike, Germany's largest e-bike refurbisher, and BusinessBike, a company leasing specialist, are creating a real circular economy with this offer – and a cheap and sustainable alternative. Customers benefit in many ways: the offer is large – and the refurbished e-bikes in the company bike leasing programme are already available in Germany at rebike.com/de/business-bike.

Heatwaves in sub-Saharan Africa are predicted to become more common due to climate change. A new study by researchers at Karolinska Institutet and others, published in Nature Medicine, reveals a worrying correlation between high temperatures in the final week of pregnancy and an increased risk of stillbirth and early neonatal mortality.

Researchers at Karolinska Institutet in Sweden and the University of Innsbruck in Austria have developed a simpler and more effective screening method for cervical cancer than the method used today. A comprehensive study published in Nature Medicine shows that the test detects significantly more cancers and precancerous stages.

Gütersloh, 08.05.2024. 60 percent of Europeans intend to cast their ballots in the European Elections in June. This would be around 10 percent more than in the last elections five years ago. This is the outcome of the new "eupinions" survey conducted by the Bertelsmann Stiftung. The survey also reveals that 75 percent of the European electorate know Ursula von der Leyen by name and face. This means that the current commission president is considerably better known than her predecessors. At the same time, 70 percent of those surveyed indicated that they felt inadequately informed about the commission president's work.

The German population is concerned about disinformation being disseminated deliberately over the internet. They fear that political opinions and elections are being influenced in this way. The political class, civil society and the media must confront this challenge. Comparison with the United States shows that polarisation boosts awareness of disinformation.

Materials and objects could take on different shapes by themselves through a method developed at KTH Royal Institute of Technology. Breakthrough tests showed how microscale melting and cooling of a wide range of materials—such as plastics and metals—can be manipulated to reorganize their mass and form new shapes.

A new method, developed at Karolinska Institutet, KTH Royal Institute of Technology and SciLifeLab in Sweden, can identify unique immune cell receptors and their location in tissue, a study published in the journal Science reports. The researchers predict that the method will improve the ability to identify which immune cells contribute to disease processes and open up opportunities to develop novel therapies for numerous diseases.

Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid therapy, in adults with pain associated with knee osteoarthritis. The U.S. Food and Drug Administration’s Breakthrough Therapy Designation process aims to expedite the development of investigational medicines intended to treat severe conditions and where preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over available therapy on clinically significant endpoints.

Today, Tuesday 16 May 2023, ERSTE Foundation is hosting the Time To Decide Europe Summit 2023 in cooperation with the Institute for Human Sciences (IWM). 15 leading European intellectuals are developing propositions and debating possible solutions for the future of Europe given the crises we are facing today. Around 300 guests are about to experience an innovative debate format on-site in Vienna.

B cells are critical to the proper functioning of the immune system. However, researchers at Karolinska Institutet have shown that they can sometimes do more harm than good, as their numbers greatly increase after bowel damage, preventing the tissue from healing. The results, which are presented in the journal Immunity, can be of significance to the treatment of inflammatory bowel disease.

Researchers at Karolinska Institutet in Sweden have conducted a pioneering study analysing internet-delivered anonymous cognitive behavioural therapy (CBT) for people who view images or videos of children being sexually abused. The participants, who were mainly recruited via forums on the encrypted part of the internet called Darknet, reported less use of such material after therapy. The study is published in the journal Internet Interventions.

Adults with ADHD are at greater risk of developing a range of cardiovascular diseases than those without the condition, according to a large observational study led by researchers at Karolinska Institutet and Örebro University in Sweden. The researchers say the findings, published in the journal World Psychiatry, underscore the need to monitor cardiovascular health in people with ADHD.

Researchers at Karolinska Institutet in Sweden are developing a coronavirus vaccine designed to be less sensitive to mutations and equipped for future strains. The vaccine showed promising results in mice in a newly published study in EMBO Molecular Medicine, and the researchers now hope to be able to take it to safety studies on humans.

Global Phase III programme to enable marketing authorisation in the EU, the US and Japan for an innovativenon-opioid investigational medicine. The programme will be conducted across approx. 200 study sites and include more than 1800 patients suffering from pain associated with osteoarthritis. Globally, more than 300 million patients suffer from osteoarthritis[1]. The global osteoarthritis market is expected to grow to approximately $11.0 billion in 2025[2]. Aachen, Germany – 18 August 2022 –Grünenthal announced today that the company has enrolled the first patient in its global clinical Phase III programme for resiniferatoxin (RTX). RTX is a highly potent Transient Receptor Potential Vanilloid 1 (TRPV1) agonist, with a well-validated mechanism of action. The discovery of TRPV1 was awarded the Nobel Prize of Physiology or Medicine in 2021. If approved, resiniferatoxin may provide patients with long-lasting pain relief with a favourable safety profile. Grünenthal’s Phase III programme wi

Aachen, Germany – 4 August 2022 – Grünenthal and Shionogi announced today that they have entered into a licensing agreement for Grünenthal’s investigational medicine Resiniferatoxin (“RTX”). Shionogi obtained the exclusive rights to commercialise Grünenthal’s asset in Japan for pain associated with osteoarthritis of the knee. RTX is currently in Phase III of clinical development for the treatment of patients with moderate to severe pain associated with knee osteoarthritis. Osteoarthritis, a progressive and often painful joint disease, is an indication with high unmet medical need. If approved, RTX could become a well-tolerated, non-opioid therapy option for patients, providing long-lasting pain relief and functional improvement of the affected knee joints. Under the terms of the agreement, Shionogi will obtain the exclusive commercialisation rights for RTX in Japan for a total consideration of up to $ 525 million plus additional sales based payments. Thereof, Shionogi will pay $ 75 mil

AcadeMedia takes the next step in realising its game education expansion plans through the acquisition of Changemaker Educations AB (Futuregames), which together with AcadeMedia´s The Game Assembly is ranked as one of the best game educations in the world.

Ett introduktionsprogram för sjuksköterskor, byggchefers organisatoriska och sociala arbetsmiljö och samband mellan stillasittande arbete, blodsockeromsättning och kognitiv dysfunktion. Det är ämnena för tre av de tio forskningsprojekt som beviljats sammanlagt 28 757 000 kronor av Afa Försäkring i 2022 års andra anslagsomgång.

Researchers at Karolinska Institutet in Sweden have identified a new vaccine candidate against pneumococci, bacteria that can cause pneumonia, sepsis, and meningitis. The vaccine molecules comprise nano-sized membrane vesicles produced by the bacteria and provide protection in mice, a new study published in PNAS reports.